175 related articles for article (PubMed ID: 30911567)
21. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
23. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
Wang Y; Lin C; Ren Q; Liu Y; Yang X
Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
[TBL] [Abstract][Full Text] [Related]
24. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
25. Simvastatin reduces TGF-β1-induced SMAD2/3-dependent human ventricular fibroblasts differentiation: Role of protein phosphatase activation.
Rizvi F; Siddiqui R; DeFranco A; Homar P; Emelyanova L; Holmuhamedov E; Ross G; Tajik AJ; Jahangir A
Int J Cardiol; 2018 Nov; 270():228-236. PubMed ID: 30220377
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
[TBL] [Abstract][Full Text] [Related]
27. The pronounced lung lesions developing in LATY136F knock-in mice mimic human IgG4-related lung disease.
Waseda Y; Yamada K; Mizuguchi K; Ito K; Watanabe S; Zuka M; Ishizuka T; Malissen M; Malissen B; Kawano M; Matsui S
PLoS One; 2021; 16(3):e0247173. PubMed ID: 33661938
[TBL] [Abstract][Full Text] [Related]
28. Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways.
Sugiyama Y; Kakoi K; Kimura A; Takada I; Kashiwagi I; Wakabayashi Y; Morita R; Nomura M; Yoshimura A
Int Immunol; 2012 Apr; 24(4):253-65. PubMed ID: 22331441
[TBL] [Abstract][Full Text] [Related]
29. Smad2 and Smad3 as mediators of the response of adventitial fibroblasts induced by transforming growth factor β1.
Ren M; Wang B; Zhang J; Liu P; Lv Y; Liu G; Jiang H; Liu F
Mol Med Rep; 2011; 4(3):561-7. PubMed ID: 21468608
[TBL] [Abstract][Full Text] [Related]
30. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
[TBL] [Abstract][Full Text] [Related]
31. Urotensin II-induced collagen synthesis in cultured smooth muscle cells from rat aortic media and a possible involvement of transforming growth factor-β1/Smad2/3 signaling pathway.
Zhao J; Ding W; Song N; Dong X; Di B; Peng F; Tang C
Regul Pept; 2013 Mar; 182():53-8. PubMed ID: 23403244
[TBL] [Abstract][Full Text] [Related]
32. Interaction of ERK1/2 and Smad2/3 signaling pathways in TGF-β1-induced TIMP-3 expression in rat chondrocytes.
Wang X; Zhu Y; Tao H; Jin C; Liu Y; Lu X; Hu X; Fan C
Arch Biochem Biophys; 2014 Dec; 564():229-36. PubMed ID: 25245272
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of transforming growth factor-beta1, connective tissue growth factor, phosphorylated-SMAD2/3 and phosphorylated-ERK1/2 during mouse tooth development.
Li S; Pan Y
J Mol Histol; 2017 Dec; 48(5-6):347-355. PubMed ID: 28825193
[TBL] [Abstract][Full Text] [Related]
34. Expression, purification, and evaluation of in vivo anti-fibrotic activity for soluble truncated TGF-β receptor II as a cleavable His-SUMO fusion protein.
Wang X; Li Y; Li X; Yan L; Guan H; Han R; Han Y; Gui J; Xu X; Dong Y; Liu H
World J Microbiol Biotechnol; 2018 Nov; 34(12):181. PubMed ID: 30474742
[TBL] [Abstract][Full Text] [Related]
35. Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model.
Hong SK; Choo EH; Ihm SH; Chang K; Seung KB
Metabolism; 2017 Nov; 76():42-55. PubMed ID: 28987239
[TBL] [Abstract][Full Text] [Related]
36. Latent TGF-beta1 protects against crescentic glomerulonephritis.
Huang XR; Chung AC; Zhou L; Wang XJ; Lan HY
J Am Soc Nephrol; 2008 Feb; 19(2):233-42. PubMed ID: 18216320
[TBL] [Abstract][Full Text] [Related]
37. GQ5 Hinders Renal Fibrosis in Obstructive Nephropathy by Selectively Inhibiting TGF-β-Induced Smad3 Phosphorylation.
Ai J; Nie J; He J; Guo Q; Li M; Lei Y; Liu Y; Zhou Z; Zhu F; Liang M; Cheng Y; Hou FF
J Am Soc Nephrol; 2015 Aug; 26(8):1827-38. PubMed ID: 25392233
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor beta1 from endometriomas promotes fibrosis in surrounding ovarian tissues via Smad2/3 signaling.
Shi LB; Zhou F; Zhu HY; Huang D; Jin XY; Li C; Dai Y; Pan YB; Zhang SY
Biol Reprod; 2017 Jan; 97(6):873-882. PubMed ID: 29136085
[TBL] [Abstract][Full Text] [Related]
39. [Is hypertrophic pachymeningitis a dural lesion of IgG4-related systemic disease?].
Riku S; Hashizume Y; Yoshida M; Riku Y
Rinsho Shinkeigaku; 2009 Sep; 49(9):594-6. PubMed ID: 19928692
[TBL] [Abstract][Full Text] [Related]
40. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
